Pricing Log in Create free account

Intensity Therapeutics Inc. (INTS) vs Palatin Technologies, Inc. (PTN)

Intensity Therapeutics Inc. and Palatin Technologies, Inc. are both Biotechnology companies. Intensity Therapeutics Inc. and Palatin Technologies, Inc. are of similar size ($11.6M and $11.0M). Intensity Therapeutics Inc. has the higher net margin (0.00% vs −63.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Intensity Therapeutics Inc. leads on 7 and Palatin Technologies, Inc. on 6.

Valuation

Metric INTS PTN Biotechnology median
P/E n/m n/m 8.50
P/S n/m 1.29 9.71
P/B 0.98 2.55 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.03 n/m 0.64
EV/Sales n/m 0.73 9.21
Earnings yield (50.85%) (49.33%) (33.15%)
Free cash flow yield (98.74%) (79.85%) (25.50%)

Profitability

Metric INTS PTN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (65.74%) 0.00%
Net margin 0.00% (63.54%) 0.00%
Free cash flow margin 0.00% (103.07%) 0.00%
Return on equity (195.88%) (877.60%) (56.36%)
Return on assets (139.85%) (142.11%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric INTS PTN Biotechnology median
Revenue growth (TTM) — 110.89% 6.02%
EPS growth (last fiscal year) 70.74% 90.79% 30.26%
Revenue growth, 5-year CAGR — 156.83% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INTS PTN Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 5.00 4.61 4.72
Net debt to EBITDA 0.99 0.87 0.96

Dividend

Metric INTS PTN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric INTS PTN Biotechnology median
Market cap 11.04m 11.55m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack